794 related articles for article (PubMed ID: 32269162)
41. New azole antifungals with a fused triazinone scaffold.
Montoir D; Guillon R; Gazzola S; Ourliac-Garnier I; Soklou KE; Tonnerre A; Picot C; Planchat A; Pagniez F; Le Pape P; Logé C
Eur J Med Chem; 2020 Mar; 189():112082. PubMed ID: 32000050
[TBL] [Abstract][Full Text] [Related]
42. Aprepitant, an antiemetic agent, interferes with metal ion homeostasis of
Eldesouky HE; Lanman NA; Hazbun TR; Seleem MN
Virulence; 2020 Dec; 11(1):1466-1481. PubMed ID: 33100149
[TBL] [Abstract][Full Text] [Related]
43. Essential Oil-Based Design and Development of Novel Anti-
Hamdy R; Fayed B; Hamoda AM; Rawas-Qalaji M; Haider M; Soliman SSM
Molecules; 2020 Mar; 25(6):. PubMed ID: 32213931
[No Abstract] [Full Text] [Related]
44. Titration of C-5 Sterol Desaturase Activity Reveals Its Relationship to Candida albicans Virulence and Antifungal Susceptibility Is Dependent upon Host Immune Status.
Regan J; DeJarnette C; Luna-Tapia A; Parker JE; Reitler P; Barnett S; Tucker KM; Kelly SL; Palmer GE
mBio; 2022 Apr; 13(2):e0011522. PubMed ID: 35380453
[TBL] [Abstract][Full Text] [Related]
45. Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata.
Sanglard D; Ischer F; Bille J
Antimicrob Agents Chemother; 2001 Apr; 45(4):1174-83. PubMed ID: 11257032
[TBL] [Abstract][Full Text] [Related]
46. Structure-activity relationship studies of ultra-short peptides with potent activities against fluconazole-resistant Candida albicans.
Ng SMS; Yap JM; Lau QY; Ng FM; Ong EHQ; Barkham T; Teo JWP; Alfatah M; Kong KW; Hoon S; Arumugam P; Hill J; Brian Chia CS
Eur J Med Chem; 2018 Apr; 150():479-490. PubMed ID: 29549835
[TBL] [Abstract][Full Text] [Related]
47. New and Promising Chemotherapeutics for Emerging Infections Involving Drug-resistant Non-albicans Candida Species.
Silva LN; de Mello TP; de Souza Ramos L; Branquinha MH; Dos Santos ALS
Curr Top Med Chem; 2019; 19(28):2527-2553. PubMed ID: 31654512
[TBL] [Abstract][Full Text] [Related]
48. Discovery of new azoles with potent activity against Candida spp. and Candida albicans biofilms through virtual screening.
Sari S; Kart D; Öztürk N; Kaynak FB; Gencel M; Taşkor G; Karakurt A; Saraç S; Eşsiz Ş; Dalkara S
Eur J Med Chem; 2019 Oct; 179():634-648. PubMed ID: 31279296
[TBL] [Abstract][Full Text] [Related]
49. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Sanglard D; Coste AT
Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
[TBL] [Abstract][Full Text] [Related]
50. A Cationic Polymer That Shows High Antifungal Activity against Diverse Human Pathogens.
Rank LA; Walsh NM; Liu R; Lim FY; Bok JW; Huang M; Keller NP; Gellman SH; Hull CM
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739790
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of Vesicular Transport Influences Fungal Susceptibility to Fluconazole.
Demuyser L; Van Dyck K; Timmermans B; Van Dijck P
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782993
[TBL] [Abstract][Full Text] [Related]
52. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
Karabıçak N; Alem N
Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
[TBL] [Abstract][Full Text] [Related]
53. Antifungal activity of Caryocar brasiliense camb. Alone or along with antifungal agents against multidrug-resistant Candida auris.
Retore YI; Lucini F; Rial RC; Cardoso CAL; Souza PFN; Simionatto S; Rossato L
J Ethnopharmacol; 2024 Aug; 330():118240. PubMed ID: 38677574
[TBL] [Abstract][Full Text] [Related]
54. Azole-triphenylphosphonium conjugates combat antifungal resistance and alleviate the development of drug-resistance.
Wang X; Liu J; Chen J; Zhang M; Tian C; Peng X; Li G; Chang W; Lou H
Bioorg Chem; 2021 May; 110():104771. PubMed ID: 33714761
[TBL] [Abstract][Full Text] [Related]
55. Cross-species discovery of syncretic drug combinations that potentiate the antifungal fluconazole.
Spitzer M; Griffiths E; Blakely KM; Wildenhain J; Ejim L; Rossi L; De Pascale G; Curak J; Brown E; Tyers M; Wright GD
Mol Syst Biol; 2011 Jun; 7():499. PubMed ID: 21694716
[TBL] [Abstract][Full Text] [Related]
56. Synergistic antifungal effect of lactoferrin with azole antifungals against Candida albicans and a proposal for a new treatment method for invasive candidiasis.
Kobayashi T; Kakeya H; Miyazaki T; Izumikawa K; Yanagihara K; Ohno H; Yamamoto Y; Tashiro T; Kohno S
Jpn J Infect Dis; 2011; 64(4):292-6. PubMed ID: 21788703
[TBL] [Abstract][Full Text] [Related]
57. Synergistic Effect of the Combination of Deferoxamine and Fluconazole
An L; Tan J; Wang Y; Liu S; Li Y; Yang L
Antimicrob Agents Chemother; 2022 Nov; 66(11):e0072522. PubMed ID: 36286552
[TBL] [Abstract][Full Text] [Related]
58. Loss of C-5 Sterol Desaturase Activity in
Luna-Tapia A; Butts A; Palmer GE
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30323044
[TBL] [Abstract][Full Text] [Related]
59. Synergistic effects of tea polyphenol epigallocatechin 3-O-gallate and azole drugs against oral Candida isolates.
Behbehani JM; Irshad M; Shreaz S; Karched M
J Mycol Med; 2019 Jun; 29(2):158-167. PubMed ID: 30797684
[TBL] [Abstract][Full Text] [Related]
60. A prenylated flavanone from Dalea elegans inhibits rhodamine 6 G efflux and reverses fluconazole-resistance in Candida albicans.
Peralta MA; Calise M; Fornari MC; Ortega MG; Diez RA; Cabrera JL; Pérez C
Planta Med; 2012 Jun; 78(10):981-7. PubMed ID: 22673834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
